Similarly, pharmacological Pin1 inhibition shrunk mammosphere forming efficiency in a dose dependent manner in MDA-MB-231 and other breast cancer cell lines (BT-549 and SUM-159), (supplementary Fig S2A left and right). This evidence concerns the gene PIN1 and breast carcinoma.